Dr Bowen is an Australian National Health & Medical Research Council Doherty Biomedical Fellow and Senior Lecturer at the University of Sydney’s Brain and Mind Centre. His research uses cutting-edge cellular and preclinical techniques to discover and develop novel pharmacotherapies for serious brain disorders that currently lack effective treatments. Some of his most important work involves the discovery and development of novel pharmacological treatments targeting the brain oxytocin system that are aimed at substance-use disorders and social disorders, such as autism. In other ongoing work, he is exploring the utility of targeting extrasynaptic GABAA receptors to treat a number of neurological and mental health disorders. More recently, he has joined the leadership team of the Lambert Initiative for Cannabinoid Therapeutics, which is exploring the therapeutical potential of cannabinoids for a range of disorders.